Revenue Breakdown
Composition ()
No data
Revenue Streams
CVS Health Corp (CVS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pharmacy, accounting for 57.9% of total sales, equivalent to $59.55B. Other significant revenue streams include Premiums and Front Store. Understanding this composition is critical for investors evaluating how CVS navigates market cycles within the Healthcare Facilities & Services industry.
Profitability & Margins
Evaluating the bottom line, CVS Health Corp maintains a gross margin of 13.42%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.87%, while the net margin is -3.88%. These profitability ratios, combined with a Return on Equity (ROE) of 0.63%, provide a clear picture of how effectively CVS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CVS competes directly with industry leaders such as GRDN. With a market capitalization of $94.17B, it holds a leading position in the sector. When comparing efficiency, CVS's gross margin of 13.42% stands against GRDN's 19.80%. Such benchmarking helps identify whether CVS Health Corp is trading at a premium or discount relative to its financial performance.
